ASX Resets Record On China Progress; Monash IVF Recovers

australian financial review
11 Jun

The Australian sharemarket climbed to a fresh intraday points record before paring gains on Wednesday after encouraging news from London where US and Chinese officials are seeking a trade truce.

The S&P/ASX 200 Index rose 4.9 points, or 0.1 per cent, to a fresh record close of 8592.1 after hitting a peak of 8639.1 in morning trading. Seven of the 11 sectors climbed, led by energy stocks and the big miners.

Investors tracked a rally on Wall Street that pushed the S&P 500 up 0.6 per cent as US Commerce Secretary Howard Lutnick said the second-day negotiations with China had gone well.

After the close of New York trading, both countries agreed to a preliminary plan to ease trade tensions between the world’s two largest economies, with officials agreeing on a framework on how to implement the consensus that had previously been reached in Geneva.

With little catalyst to drive the sharemarket much higher from here, investors are now awaiting key US inflation data tonight, the last key economic figures before next week’s Federal Reserve meeting.

On the ASX, Woodside Energy led oil stocks higher, rallying 1.9 per cent to $23.5. BHP Group climbed 1.5 per cent to $39.1 as iron ore inched higher in Singapore. Modest gains in ANZ and Westpac also buoyed the market, but Commonwealth Bank fell 0.3 per cent to $181.4 after earlier hitting a fresh record of $181.4.

Hugh Dive, chief investment officer at Atlas Funds Management said American investment managers keen to gain exposure to Australian domestic stocks, like Fisher Investments, which the Australian Financial Review last week reported has spent as much as $1 billion buying up Commonwealth Bank, were driving the ASX’s record high.

“I’m sure there’s a fair few of those US fund managers looking to get out of America and get exposure to some boring Australian domestic names, which has fuelled this blow up, even as fundies like myself have been selling CBA over the last few months,” Dive said.

“There’s lots of green going through the screen, but it feels like it’s getting harder and harder to rise each day because the ASX is already at such lofty levels.

“Most people are a bit concerned about the larger end of the market given the massive price to earnings expansion that we’ve seen in the last month – can it be sustained?”

Stocks in focus

In corporate news, Monash IVF rallied 11 per cent to 61¢ after plunging 28 per cent on Tuesday when the fertility giant’s management revealed an embryo mix-up at its Melbourne laboratory – the second bungle that the company has been forced to disclose in three months.

Johns Lyng Group rocketed 17.7 per cent to $3 after confirming reports in The Australian Financial Review’s Street Talk column of a non-binding indicative offer proposal from Pacific Equity Partners.

Buy now, pay later giant Zip jumped 15.5 per cent to $2.7 after upgrading its earnings guidance.

New Zealand-based building materials group Fletcher Building jumped 10 per cent to $3.1 after revealing that it had received “ongoing inbound inquiries” from parties interested in its businesses, including the construction division.

Qantas declined 1.3 per cent to $10.5 despite announcing plans to close Jetstar Asia, the Singapore-based budget airline it launched more than two decades ago to capture a lucrative Asian market.

Mortgage insurer Helia rose 0.8 per cent to $5.3 after announcing that chief executive and managing director Pauline Blight-Johnston would stand down after more than five years in the role.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10